Clinical Trial Update: A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase II trial comparing raltitrexed/oxaliplatin plus radiotherapy versus radiotherapy alone in patients with inoperable esophageal cancer (Stage I–III).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Raltitrexed (Raltitrexed)

Snippet

Sponsor: The First People's Hospital of Lianyungang | Conditions: Inoperable Esophageal Cancer Stage I-III | Phase 2 | Status: UNKNOWN